Tran Benjamin B 4
4 · Bimergen Energy Corp · Filed Aug 28, 2025
Insider Transaction Report
Form 4
Tran Benjamin B
DirectorChief Executive Officer10% Owner
Transactions
- Award
Options (Right to Buy)
2025-08-26+142,858→ 142,858 totalExercise: $4.50Exp: 2034-04-24→ Common Stock (142,858 underlying) - Disposition to Issuer
Options (Right to Buy)
2024-04-24+142,858→ 142,858 totalExp: 2034-04-24→ Common Stock (142,858 underlying)
Footnotes (3)
- [F1]The Exercise Prices for the options specified in the table above (the "Options") are as follows: (a) for the first 1/5th of the Options, $0.50 per share of Common Stock which may be exercised on or after the first annual anniversary of the Award Date; (b) for the second 1/5th of the Options, $0.75 per share of Common Stock which may be exercised on or after the second annual anniversary of the Award Date; (c) for the third 1/5th of the Options, $1.00 per share of Common Stock which may be exercised on or after the third annual anniversary of the Award Date; (d) the fourth 1/5th of the Options, $1.25 per share of Common Stock which may be exercised on or after the fourth annual anniversary of the Award Date; and (e) for the final 1/5th of the Options, $1.50 per share of Common Stock which may be exercised on or after the fifth annual anniversary of the Award Date.
- [F2]The Date Exercisable for the options specified in the table above (the "Options") are as follows: (a) for the first 1/5th of the Options may be exercised on or after the first annual anniversary of the Award Date; (b) for the second 1/5th of the Options may be exercised on or after the second annual anniversary of the Award Date; (c) for the third 1/5th of the Options may be exercised on or after the third annual anniversary of the Award Date; (d) the fourth 1/5th of the Options may be exercised on or after the fourth annual anniversary of the Award Date; and (e) for the final 1/5th of the Options may be exercised on or after the fifth annual anniversary of the Award Date.
- [F3]On August 26, 2025, the Issuer's Board of Directors approved an option repricing (the "Repricing") whereby the Reporting Person's options were repriced to an exercise price of $4.50 per share. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.